Related Experiment Video
Updated: May 7, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Dietary interventions for primary allergy prevention--what is the evidence?
Insights
Early infant nutrition impacts allergy risk. Reducing allergen exposure through breastfeeding or hydrolyzed formulas may prevent eczema, but timing of complementary foods is key for all infants.
Area of Science:
- Pediatrics
- Allergy and Immunology
- Nutrition Science
Background:
- Early life allergen exposure, particularly through infant nutrition, is a significant risk factor for developing allergic diseases.
- Primary allergy prevention strategies focus on reducing dietary allergen load in high-risk infants.
Purpose of the Study:
- To review current evidence on various infant feeding strategies for allergy prevention.
- To provide guidance on optimal nutritional interventions for infants at risk of allergies.
Main Methods:
- Systematic review of studies on breastfeeding, maternal diets, hydrolyzed infant formulas, and complementary feeding.
- Analysis of data regarding the efficacy of different interventions on allergic disease development.
Main Results:
- Breastfeeding shows mixed results for allergy prevention; hydrolyzed formulas may reduce atopic eczema risk.
- Maternal dietary restrictions are not recommended during pregnancy or lactation due to lack of benefit and potential harm.
- Introducing complementary foods between 5-6 months is recommended for all infants, regardless of feeding type.
Conclusions:
- Infant feeding strategies, including formula selection and timing of solids, play a crucial role in allergy prevention.
- Evidence supports hydrolyzed formulas for eczema prevention and timely complementary feeding for all infants.
- Further research is needed to understand factors influencing formula efficacy beyond protein hydrolyzation.
Abstract:
Allergen exposure in the early postnatal life of an infant with a genetic predisposition for allergy is regarded as at least one essential risk factor for later development of allergic diseases. The most important allergen exposure in early life derives from the early nutrition of the baby. Thus, intervention based on the concept of reducing the allergen load in the diet is one approach for primary allergy prevention in children at risk. This includes breastfeeding, allergen-reduced diet of the pregnant and lactating mother, cow milk protein hydrolysate infant formulas (= hypoallergenic infant formula or HA formulas) and time of introduction of complementary food. Data on breastfeeding regarding allergy prevention are inconsistent: preventive with regard to atopic eczema and cow milk allergy in the first 2 years, but contradictory regarding wheezing beyond the first years of life. Allergen-reduced diet of the pregnant mother is not recommended because there is no evidence for a preventive benefit, but instead for unwanted effects on the child's intrauterine development. Data on a restrictive diet during lactation are also inconsistent. If breastfeeding is insufficient in the first 4-6 months, both partially and extensively hydrolyzed formulas have been successfully used to reduce the risk for atopic eczema, but not for asthma or allergic rhinitis, until school age. However, from the available data it is suggested that the preventive potential of a formula is not only dependent on the degree of hydrolyzation and the protein source, but also from other factors like the process of manufacturing the formula. Recommendations for a certain formula should therefore be based on its proven efficacy in controlled clinical trials. For all healthy children with and without risk for allergy, more recent findings support complementary food introduction in the 5th and 6th months--independent of the kind of milk feeding--according to the nutritional needs and abilities of a baby. Delayed introduction of complementary food beyond the 6th month is no longer recommended.
Related Concept Videos
Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cancer Prevention
Some...
Allergic Reactions: Anaphylaxis
Asthma-I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

